Rizatriptan clinical trials
Also written Maxalt and MK0462.
How each study uses rizatriptan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the rizatriptan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Jun 1998 · MAXALT · NDA 020864 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
22 studies that test it; most in 1995 (5)
| Year | Studies |
|---|---|
| 1995 | 5 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 1 |
| 2014 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 9
Organon and Co (12) · Diamond Headache Clinic (2) · Eurofarma Laboratorios S.A. (1) · Robert W. Baloh (1) · Beth Israel Deaconess Medical Center (1) · University of Pittsburgh (1) · Universität Duisburg-Essen (1) · Clinvest (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses rizatriptan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine HeadacheRecruitingPhase 4Antonios LikourezosNCT06473597Written as Rizatriptan Benzoate
- Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of MigraineCompletedPhase 3Eurofarma Laboratorios S.A.NCT04384367Written as Rizatriptan 10 mg + Naproxen 550mg
- A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine ProphylaxisCompletedPhase 3Organon and CoNCT00812006Written as rizatriptan benzoate
- A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)CompletedPhase 3Organon and CoNCT00894556Written as rizatriptan
- A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)CompletedPhase 3Organon and CoNCT01001234Written as rizatriptan
- A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)CompletedPhase 3Organon and CoNCT01004263Written as rizatriptan benzoate
- Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)CompletedPhase 3Organon and CoNCT00516737Written as Comparator: rizatriptan benzoate
- Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)CompletedPhase 1Organon and CoNCT00604812Written as rizatriptan benzoate (5 mg)
- MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)CompletedPhase 3Organon and CoNCT00897104Written as rizatriptan benzoate (MK0462)
- Study to Test a Marketed Product in the Treatment of Migraine-associated NauseaCompletedPhase 3Organon and CoNCT00250458Written as Comparator: Rizatriptan
- MK0462 in Treatment of Migraine With Recurrence (MK0462-022)CompletedPhase 3Organon and CoNCT00897949Written as rizatriptan benzoate (MK0462)
- Treatment of Multiple Attacks of Acute Migraine (0462-025)CompletedPhase 3Organon and CoNCT00899379Written as rizatriptan benzoate
- Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)CompletedPhase 3Organon and CoNCT01286207Written as Rizatriptan 5 mg
- Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)CompletedPhase 3Organon and CoNCT00898677Written as rizatriptan benzoate
- Rizatriptan for Episodic Dizziness in Vestibular MigraineCompletedPhase 2/3Robert W. BalohNCT02447991Written as Rizatriptan
- Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military TroopsWithdrawnNot applicableHenry M. Jackson Foundation for the Advancement of Military MedicineNCT01306266Written as Rizatriptan
- The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine HeadacheCompletedPhase 4Beth Israel Deaconess Medical CenterNCT00719134Written as Maxalt
- Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?CompletedNot applicableUniversity of PittsburghNCT00360282Written as Rizatriptan
- Rizatriptan 10 MG RPD in the Treatment of Acute MigraineCompletedPhase 4Universität Duisburg-EssenNCT01057160Written as Rizatriptan
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine HeadacheCompletedPhase 3Diamond Headache ClinicNCT00471952Written as Maxalt 10mg MLT plus Caffeine 75mg
See all 22 studies that test rizatriptan →
As the comparator · 3 — what is tested is compared with rizatriptan
- Maximizing Outcomes in Treating Acute MigraineCompletedPhase 3Axsome Therapeutics, Inc.NCT03896009Written as Rizatriptan
- Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)CompletedPhase 3Merck Sharp & Dohme LLCNCT00443209Written as Rizatriptan 10 mg tablets
- A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)CompletedPhase 2Merck Sharp & Dohme LLCNCT00246337Written as Rizatriptan
Codes
What other systems call rizatriptan · ClinicalTrials.gg INT003845
- MeSH (NLM) C093622rizatriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 51086HBW8GRIZATRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 88014Confirmed FDA, Wikidata
- Wikidata Q212171rizatriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61930RizatriptanOne source FDA
- DrugBank DB00953One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C093622 | rizatriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 51086HBW8G | RIZATRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 88014 | — | Confirmed FDA, Wikidata |
| Wikidata | Q212171 | rizatriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61930 | Rizatriptan | One source FDA |
| DrugBank | DB00953 | — | One source Wikidata |
Also registered as rizatriptan benzoate (UNII WR978S7QHH · RxNorm 237082).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.